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Abstract: Boron nitride nanotubes (BNNTs) have attracted huge attention in many different 
research fields thanks to their outstanding chemical and physical properties. During recent years, 
our group has pioneered the use of BNNTs for biomedical applications, first of all assessing 
their in vitro cytocompatibility on many different cell lines. At this point, in vivo investigations 
are necessary before proceeding toward realistic developments of the proposed applications. 
In this communication, we report a pilot toxicological study of BNNTs in rabbits. Animals 
were injected with a 1 mg/kg BNNT solution and blood tests were performed up to 72 hours 
after injection. The analyses aimed at evaluating any acute alteration of hematic parameters 
that could represent evidence of functional impairment in blood, liver, and kidneys. Even if 
preliminary, the data are highly promising, as they showed no adverse effects on all the evalu-
ated parameters, and therefore suggest the possibility of the realistic application of BNNTs in 
the biomedical field.
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Introduction
Boron nitride nanotubes (BNNTs), similar to carbon nanotubes (CNTs), have   
attracted wide attention thanks to their potentially unique and important properties in 
structural and electronic applications.1,2 A BNNT is a structural analog of a CNT, but, 
despite this similarity, it presents many different chemical and physical properties. For 
instance, BNNTs display excellent mechanical properties, with a measured Young’s 
modulus of 1.22 ± 0.24 TPa. Moreover, while CNTs exhibit either a semiconductive or 
conductive behavior depending on chirality and diameter, BNNTs have only a constant 
band gap of about 5.5 eV .3 Ab initio calculations4 and experimental data,5 moreover, 
demonstrated that they work as excellent piezoelectric systems, with response values 
larger than those of piezoelectric polymers and comparable to those exhibited by 
wurtzite semiconductors.
BNNTs have also attracted attention in the fields of nanomedicine, both as 
  nanovectors for drug delivery purposes6 and as intracellular nanotransducers.7 Data 
on cytocompatibility of these innovative nanovectors come from studies of BNNTs 
incubated with different cell types, like human embryonic kidney cells, HEK 293; 
Chinese hamster ovary cells, CHO;8 human osteoblasts or mouse macrophages;9 
human neuroblastoma cells, SH-SY5Y;10 mouse myoblasts, C2C12;11 and neuronal-
like PC12 cells.7
Results reported by many groups strongly agree about the optimal   cytocompatibility 
of BNNTs, as their administration did not affect cell proliferation, metabolism, 
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and differentiation. However, a recent report by Horvath 
and coworkers outlined possible adverse effects of BNNTs 
on fibroblasts, macrophages, and lung cells.12 A possible 
explanation for such different results may deal with the 
considerable length (tens of microns) of the tested BNNTs: 
the toxicity of nanomaterials is, in fact, well-known as being 
connected to the aspect ratio of tubular nanostructures.13
At this point, as extensive cytocompatibility investi-
gations of BNNTs have been performed, in vivo testing 
(ie, biocompatibility studies) is fundamental to answer 
open questions and direct scientific efforts toward realistic 
applications of BNNTs in the biomedical fields. Here, we 
report the first toxicology investigation of BNNTs in animals. 
Although preliminary, our results suggest a good response of 
the subjects to intravenous injections of BNNT dispersions, 
with no adverse effects on blood cells, liver, and kidneys.
Materials and methods
Preparation of BNNT dispersions
BNNTs were purchased from the Nano and Ceramic 
  Materials Research Center, Wuhan Institute of Technology, 
  China.14 Details about production and characterization of the 
samples, and about the preparation of the dispersions, can 
be found elsewhere.10 Briefly, glycol chitosan (G-chitosan, 
G7753; Sigma-Aldrich Co, St Louis, MO) was used for the 
stabilization of BNNTs in aqueous medium, and nanotube 
noncovalent coating was achieved through sonication at 20 W 
for 12 hours with a Bransonic Sonicator 2510 (Danbury, CT). 
In this study, dispersions were prepared in physiological 
solution (0.9% NaCl; Eurospital, Trieste, Italy) by mixing 
polymer and BNNTs at a 1:1 (w/w) ratio, thus achieving a 
final concentration of 1 mg/mL BNNTs, coated with 1 mg/
mL of G-chitosan. Before injection, dispersions were auto-
claved for sterilization.
Characterization of BNNT dispersions
Microphotographs of the final dispersions of BNNTs were 
obtained through focused-ion beam microscopy (FIB) with a 
FEI 200 microscope (FEI HQ, Hillsboro, OR). Transmission 
electron microscopy (TEM) was performed with a Zeiss 
902 TEM (Carl Zeiss, GmbH, Germany) dropping a small 
quantity of BNNT aqueous suspension (diluted 1000×) on a 
copper grid. For atomic force microscopy (AFM) imaging, 
50 µL of BNNT solution (diluted 2500×) was deposited on 
freshly cleaved, highly ordered pyrolitic graphite (HOPG; 
Bruker AXS, Inc, Madison, WI). Graphite substrates were 
incubated for 6 minutes and rinsed five times with 100 µL 
of pure water. Samples were then vacuum dried using a 
Laboport vacuum pump (KNF Neuberger, Inc, Trenton, NJ). 
Imaging was performed on a Multimode scanner with 
a Nanoscope V controller, using the Scan-Assyst mode 
(Bruker AXS). Imaging scan rate was 1.95 Hz for a scan 
size of 250 nm. Images were recorded at 512 × 512 pixels 
and stripe noise was evaluated using the DeStripe server.15 
V-shaped silicon nitride cantilevers with silicon tips (SNL; 
Bruker AXS) with a nominal spring constant of 0.35 N/m were 
used. Imaging forces were maintained below 100 pN.
Particle size distribution and Z-potential of the dispersions 
were analyzed with a Nano Z-Sizer 90 (Malvern Instruments 
Ltd, Malvern, UK). For both analyses, each acquisition was 
performed three times, using samples appropriately diluted 
in physiological solution.
Animal treatment
Five male New Zealand rabbits, aged 8–9 months, and 
  weighing 2.0 ± 0.1 kg, were used in the present study. Animal 
care and handling were performed according to the provisions 
of Council Directive 86/609 EEC, recognised and adopted by 
the Italian   Government (DL 27/1/1992, n 16). The   experimental 
Beam
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Figure 1 (A) Focused-ion beam microscopy image of G-chitosan-coated boron nitride nanotubes (BNNTs) and (B) transmission electron microscopy analysis showing the 
typical BNNT structure.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
20
Ciofani et alInternational Journal of Nanomedicine 2012:7
protocol was approved by the Ethics Committee of the 
  University of Pisa and by the Italian Ministry of Health 
(authorization n 4886, 04/04/2011). Animal health was 
clinically assessed through physical examination and com-
plete hematological analyses before experimental sessions.
Rabbits were housed in single cages, under conventional 
conditions of ventilation, temperature (18°C–22°C) and 
lighting (16-hour light:day cycle). Animals were allowed 
to adjust to their environment for 1 week. Food and water 
were available ad libitum during the whole trial. Animals 
had a diet of complete premixed food for rabbits (Consorzio 
Agrario della Maremma Toscana, Grosseto, Italy) and alfalfa 
hay. For the whole experimental period, general rabbit health 
was daily monitored by qualified personnel supervised by a 
veterinary physician.
Animals were randomly assigned to two groups: a control 
group (I, n = 2) and an experimental group (II, n = 3). Each 
subject in group I and group II received a single intravenous 
dose (1 mg/kg) of plain G-chitosan and G-chitosan-coated 
BNNTs in the morning. The two solutions, having a con-
centration of 1 mg/mL, allowed for injections of about 2 mL 
volume. Solutions were slowly injected into the marginal 
ear vein of animals placed in restraining cages. Objective 
symptoms such as sweating, excitement, trembling, and head 
nodding were scored. Body temperature was also assessed 
during the study. Blood samples were collected for analysis at 
intervals of 0, 2, 24 and 72 hours by the contralateral marginal 
ear vein used for administration, and they were placed in col-
lection tubes containing appropriate anticoagulants. Blood 
samples were processed and analyzed at the Biochemistry 
Clinical Veterinary Laboratory of the Veterinary Teaching 
Hospital, Pisa, Italy, within 2 hours of collection.
Results and discussion
BNNTs were produced by using an annealing method from 
boron-containing precursors. Details of sample, provided by 
60 nm
AB
Figure 2 (A) Height and (B) phase atomic force microscopy images of G-chitosan 
coated boron nitride nanotubes.
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Figure 3 (A) Size distribution and (B) Z-potential analyses of the injected boron nitride nanotube dispersions.
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the supplier included a boron nitride content . 98.5 wt% 
and yield of the procedure . 80%. A more detailed charac-
terization of BNNTs and of their dispersions was reported 
in a previous work.10
Figure 1 shows the results of FIB and TEM imaging on 
the G-chitosan-coated BNNTs used in animal experiments. 
The presence of tubular structures with random orientation 
and quite dispersed size distribution (tube diameters were 
between 30 nm and 100 nm and lengths between 0.5 µm and 
2.0 µm) can be seen in the FIB image (Figure 1A), whereas 
the typical bamboo-like structure of BNNTs,16 associated 
with a thin G-chitosan coating (around the BNNT walls), 
can be appreciated in the TEM image (Figure 1B).
AFM imaging shows an isolated nanotube: in the height 
image (Figure 2A), the nanotube appears as a bright line with 
edges decorated by globular structures, whereas it appears as 
a dark line decorated by brighter globular structures in the 
phase image (Figure 2B). The latter once more confirms the 
efficiency of G-chitosan-coating procedure: the phase delay 
introduced by the globular structures, which can be appre-
ciated through the brighter color, is due to the G-chitosan 
lower stiffness with respect to that of BNNTs, which in fact 
display a darker color.17
To characterize BNNT assembling in aqueous medium 
and to gain an idea of the actual sizes of the nanocomplexes 
in the injected dispersions (FIB, TEM, and AFM analyses 
were carried out on dried samples), dynamic light scattering 
and Z-potential analyses were performed in physiological 
solution. Dynamic light scattering revealed a 96.5% peak 
at a size of about 560 nm, with a polydispersion index 
of 0.250 (Figure 3A). Moreover, a Z-potential of about 
15 mV denoted a good stability of the obtained dispersion 
(Figure 3B).
During the whole study period, neither unusual behavior, 
such as sweating, excitement, trembling, and head nodding, 
nor differences could be observed between the two groups. 
Moreover, no significant changes in body temperature were 
observed up to 72 hours following the injection.
Results on hematological analyses are reported in 
detail in Table 1. Typical blood values (white cell count, 
red cell count, platelet count, etc) are not significantly dif-
ferent between control (I, ie, treated with G-chitosan) and 
experimental (II, ie, treated with G-chitosan-coated BNNTs) 
groups. Only platelet count seems to be increased at 72 hours 
after injection in the BNNT-treated group, but this value is 
still in the healthy range tabulated for rabbits.18
Blood biochemical parameters quantifying both renal 
(urea and creatinine) and hepatic (alkaline phosphatase, 
γ-glutamyl transferase, aspartate transferase, and alanine 
amino transferase) functions were also satisfactory: no 
substantial differences can be appreciated between the two 
groups at each time-point analysis.
Conclusion
This study demonstrates the first in vivo toxicity evaluation 
of BNNTs following intravenous injection. Single admin-
istrations of high doses did not produce evident toxicity in 
rabbits within the 72 hours following injection. Because 
of the small number of animals, our findings must be con-
sidered preliminary; nonetheless, the absence of negative 
effects on blood parameters, as well as liver and kidney 
functions is highly promising for further biocompatibility 
exploration of BNNTs. Future investigations will consist of 
dose-response and long-term studies. Particular attention will 
be also given to the investigation of the BNNT biodistribu-
tion and pharmacokinetics that are strictly dependent on the 
physicochemical characteristics of the nanoparticles, such 
as size, shape, aggregation, chemical composition, surface 
functionalizations, and solubility.19
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